Healthcare provider profile · identity verified

Jason Pd Bailey, MD

Family Practice · ATLANTA, GA · NPI 1689331696

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	243	68
Furosemide	Furosemide	158	29
Gabapentin	Gabapentin	127	33
Eliquis	Apixaban	99	29
Amlodipine Besylate	Amlodipine Besylate	97	34
Potassium Chloride	Potassium Chloride	97	28
Trazodone Hcl	Trazodone Hcl	87	21
Pantoprazole Sodium	Pantoprazole Sodium	80	33
Sertraline Hcl	Sertraline Hcl	74	18
Metformin Hcl	Metformin Hcl	70	17
Hydralazine Hcl	Hydralazine Hcl	66	21
Metoprolol Tartrate	Metoprolol Tartrate	60	17
Tamsulosin Hcl	Tamsulosin Hcl	60	19
Jardiance	Empagliflozin	56	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	55	19
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	54	13
Pregabalin	Pregabalin	54	15
Clopidogrel	Clopidogrel Bisulfate	53	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	20
Doxycycline Hyclate	Doxycycline Hyclate	52	13
Losartan Potassium	Losartan Potassium	51	16
Oxycodone Hcl	Oxycodone Hcl	51	20
Levetiracetam	Levetiracetam	46	11
Omeprazole	Omeprazole	45	13
Carvedilol	Carvedilol	44	17
Tramadol Hcl	Tramadol Hcl	44	26
Montelukast Sodium	Montelukast Sodium	43	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	40	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	37	25
Buspirone Hcl	Buspirone Hcl	36	suppressed
Olanzapine	Olanzapine	35	suppressed
Lisinopril	Lisinopril	34	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	14
Donepezil Hcl	Donepezil Hcl	31	suppressed
Metoprolol Succinate	Metoprolol Succinate	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	14
Lorazepam	Lorazepam	30	14
Lacosamide	Lacosamide	29	suppressed
Humalog	Insulin Lispro	27	16
Mirtazapine	Mirtazapine	27	13
Risperidone	Risperidone	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Famotidine	Famotidine	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	11
Divalproex Sodium	Divalproex Sodium	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	15
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Levofloxacin	Levofloxacin	22	11
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	21	21
Alprazolam	Alprazolam	21	suppressed
Fluconazole	Fluconazole	21	suppressed
Novolog	Insulin Aspart	21	suppressed
Movantik	Naloxegol Oxalate	20	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	14
Trulicity	Dulaglutide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Clonidine Hcl	Clonidine Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Brilinta	Ticagrelor	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Phenytoin	Phenytoin	14	suppressed
Prednisone	Prednisone	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Methimazole	Methimazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Allopurinol	Allopurinol	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Ozempic	Semaglutide	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error